N@N

DCAI, ELOY, VG, NURO, ENMD, LUNA Expected To Be Lower After Earnings Releases on Wednesday

^{Published on 2009-07-30 09:38:37, Last Modified on 2010-12-22 14:38:58 - WOPRAI}
 

July 30, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, August 5th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Dialysis Corp (NASDAQ: DCAI), eLoyalty (NASDAQ: ELOY), Vonage Holdings (NYSE: VG), NeuroMetrix (NASDAQ: NURO), EntreMed (NASDAQ: ENMD) and Luna Innovations (NASDAQ: LUNA) are all expected to be lower after their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Wednesday:

Symbol Company # of Reports Quarter Release Time

DCAI Dialysis Corporation 12 quarters Q2 After

ELOY eLoyalty Corporation 12 quarters Q2 After

VG Vonage Holdings Corp. 12 quarters Q2 Before

NURO NeuroMetrix Inc. 12 quarters Q2 Before

ENMD EntreMed Inc. August earnings Q2 Before

LUNA Luna Innovations Inc 12 quarters Q2 After

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Dialysis Corporation of America (NASDAQ: DCAI), through its subsidiaries, develops, owns, and operates outpatient kidney dialysis centers in the United States and internationally. It offers outpatient hemodialysis services, home and peritoneal dialysis services, inpatient hemodialysis services, and ancillary services associated with dialysis treatments. The company provides dialysis and ancillary services to patients suffering from chronic kidney failure, also known as end-stage renal disease. It also offers acute inpatient dialysis treatments in hospitals, homecare services, and dialysis center management services. As of December 31, 2008, the company operated 37 outpatient dialysis facilities in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and South Carolina. In addition, it distributes medical products, primarily disposables and diabetic supplies to hospitals, blood banks, laboratories, and retail pharmacies, as well as offers a line of blood lancets used to draw blood for testing. Dialysis Corporation was founded in 1976 and is based in Linthicum, Maryland.

eLoyalty Corporation (NASDAQ: ELOY) offers consulting and managed services. The company operates in two segments, the Behavioral Analytics Service and Integrated Contact Solutions/CRM. The Behavioral Analytics Service segment focuses on solutions that improve the reliability of call recording, and apply human behavioral modeling to analyze and improve customer interactions, as well as provides marketing application hosting and email fulfillment services. The Integrated Contact Solutions/CRM segment focuses on helping clients realize the benefits of transitioning their contact centers to a single network infrastructure from the traditional two-network model, which include voice network and data network. It also involves in operational consulting and integrating or building a system for the client, as well as provides remote application support services. In addition, this segment engages in the resale of third-party software and hardware. The company serves customers through direct contractual relationships in the United States, Canada, Europe, and Australia. eLoyalty Corporation was founded in 1994 and is based in Lake Forest, Illinois.

Vonage Holdings Corp. (NYSE: VG), through its subsidiaries, provides broadband Voice over Internet Protocol services to residential and small business and home office customers. It offers various features, such as call waiting, caller ID with name, call forwarding, and voicemail. The company also provides area code selection, number portability, online account management, and personalized Web-enabled voicemail. In addition, it offers services, including Vonage visual voicemails, virtual phone numbers, toll free numbers, and residential and business fax services, as well as Vonage SoftPhone, a software application that is downloaded and installed on computers, laptops, and WiFi-enabled personal digital assistant devices, which enables user to use a computer as a telephone. Further, the company offers Vonage-enabled devices, such as Vonage V-Portal to connect up to two Vonage lines through a high-speed Internet connection and includes a networking router; analog telephone adapters, which convert analog audio signals into digital data packets for transmission over the Internet; integrated adapters and wireless routers; Vonage Bundled Cordless Phone; V-phone, a USB compatible device; and Vonage Companion, a downloadable softphone that can be loaded on a laptop or PC. As of December 31, 2008, it had approximately 2.6 million subscriber lines in service. The company was incorporated in 2000 and is headquartered in Holmdel, New Jersey.

NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company, engages in the development and commercialization of products that aid physicians in the assessment, treatment, and repair of peripheral nerve and spinal cord injuries and disorders, and that provide regional anesthesia and pain control. The company provides ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and needle electromyography procedures; NC-stat System, a point-of-service neurodiagnostic solution for the performance of nerve conduction studies; and consumables and accessories for use with its neurodiagnostic equipment. Its products under development include ASCEND, a nerve localization system, which is in the clinical stage of development for minimally invasive delivery of therapeutic agents using a proprietary delivery system for regional anesthesia, pain control, and the treatment of neuropathies; and Andara OFS, an investigational device for the treatment of acute spinal cord injuries. The company offers NC-stat System primarily to primary care and internal medicine physicians; and ADVANCE NCS/EMG System to neurologists, physical medicine and rehabilitation physicians, neurosurgeons, orthopedic and hand surgeons, and pain medicine physicians. It sells its products directly to physician offices, clinics, and hospitals in the United States and internationally. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.

EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, develops therapeutic candidates primarily for the treatment of cancer and inflammation. The companya�s clinical development products include ENMD-2076, an Aurora A and angiogenic kinase inhibitor with potent activity against Aurora A and multiple tyrosine kinases linked to cancer and inflammatory diseases; used to treat tumor regression in various xenograft models, such as breast, colon, and leukemia; an activity towards ex vivo-treated human leukemia patient cells; and in Phase I clinical studies to treat solid tumors and multiple myeloma. Its clinical development products also include MKC-1, an oral cell-cycle inhibitor with activity against the mTOR pathway, which is in multiple Phase II clinical trials for metastatic breast, non-small cell lung, leukemia, pancreatic, ovarian/endometrial, and solid cancer tumors; ENMD-1198, an antimitotic agent that is in Phase I studies that induces cell cycle arrest and apoptosis in tumor cells; and Panzem, a Phase I clinical trial candidate for the treatment of rheumatoid arthritis. The company has license agreements with Childrena�s Hospital Medical Center Corporation and Celgene Corporation. EntreMed, Inc. was founded in 1991 and is headquartered in Rockville, Maryland.

Luna Innovations Incorporated (NASDAQ: LUNA) engages in the research, development, and commercialization of technologies in the areas of sensing, and instrumentation products; and health care products. It operates through two segments, Products and Technology Development. The Products segment offers test and measurement products to monitor the integrity of fiber optic network and sub-assemblies to manufacturers and suppliers; Optical Vector Analyzer platform that allows manufacturers and suppliers of optical components and sub-assemblies to reduce costs; Optical Backscatter Reflectometer, a sensitive diagnostic device for data and telecommunications companies, and service providers who maintain their own fiber optic networks; and Phoenix laser, a MEMs-based external cavity laser. This segment also provides distributed sensing systems, which comprise multiple sensors whose input is integrated through a fiber optic network and software to detect distributed strain and distributed shape; tunable lasers; and test and measurement equipment for non-destructive industrial testing applications. Its health care products include medical devices for minimally invasive diagnostics and surgery; medical devices for non-invasive monitoring and diagnosis; Emboli Detection and Classification QUANTIFIER, a non-invasive medical device that uses quantitative ultrasound technology to count emboli in ex-vivo blood circuit; and nanomaterial-based medical products, including Trimetasphere nanomaterials. The Technology Development segment provides applied research services. Luna Innovations Incorporated serves energy, telecommunications, life sciences, and defense industries in the United States. The company was incorporated in 1990 and is headquartered in Roanoke, Virginia. On July 17, 2009, Luna Innovations Incorporated along with its affiliate filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Western District of Virginia, Roanoke.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.6 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641